Predictors for cannabis cessation during pregnancy: a 10-year cohort study
Open Access
- 24 February 2024
- journal article
- research article
- Published by Taylor & Francis in Journal of Psychosomatic Obstetrics & Gynecology
- Vol. 45 (1) , 2319290
Abstract
The aim of this study is to determine factors associated with cannabis discontinuation, to assess the impact of mental health and addiction interventions on cannabis discontinuation during pregnancy and to investigate the neonatal impact of cannabis discontinuation. This is a 10-year cohort study in a tertiary hospital in Barcelona, Spain, including women with self-reported cannabis use during pregnancy. Main outcome was cannabis discontinuation based on biological sample testing. Secondary outcomes were neonatal intensive care unit (NICU) admission, preterm birth, birth weight and bottle-feeding. When cannabis use was detected during pregnancy, 32 out of 81 (38.3%) discontinued cannabis during pregnancy vs. four out of 61 (6.6%) when detected at birth (p < .001). Multivariate binary logistic regression showed that null parity (OR: 6.95, p = .011), detection of cannabis use during pregnancy (OR: 5.35, p = .018) and early detection and referral to mental health care for counseling on cannabis cessation and interventions on the first trimester (OR: 25.46, p < .001) increased cannabis discontinuation. Risk for preterm birth <37 weeks (11.4% vs. 30.8%) and NICU admission (25.7% vs. 54.2%) were lower when discontinuation. Early detection of cannabis use during pregnancy, cessation counseling with mental health interventions, and null parity are predictors for cannabis discontinuation during pregnancy.Keywords
This publication has 30 references indexed in Scilit:
- Guideline No. 425b: Cannabis Use Throughout Women’s Lifespans – Part 2: Pregnancy, the Postnatal Period, and BreastfeedingJournal of Obstetrics and Gynaecology Canada, 2022
- Correlates of continued cannabis use during pregnancyDrug and Alcohol Dependence, 2021
- Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment ratesThe Lancet Regional Health - Europe, 2021
- Cannabis-related diagnosis in pregnancy and adverse maternal and infant outcomesDrug and Alcohol Dependence, 2021
- Beliefs and attitudes regarding prenatal marijuana use: Perspectives of pregnant women who report useDrug and Alcohol Dependence, 2019
- Smoking cessation support and obstetric outcomes in an Irish maternity hospitalEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2018
- Cannabis Use During the Perinatal Period in a State With Legalized Recreational and Medical Marijuana: The Association Between Maternal Characteristics, Breastfeeding Patterns, and Neonatal OutcomesThe Journal of Pediatrics, 2018
- Trends in Self-reported and Biochemically Tested Marijuana Use Among Pregnant Females in California From 2009-2016JAMA, 2017
- Trends in Marijuana Use Among Pregnant and Nonpregnant Reproductive-Aged Women, 2002-2014JAMA, 2017
- Tobacco, alcohol and cannabis use during pregnancy: Clustering of risksDrug and Alcohol Dependence, 2014